Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionbeta-catenin binding

BCL9L CTNNA1 CTNNA2 CTNNA3

3.44e-05120314GO:0008013
GeneOntologyMolecularFunctionactin filament binding

MYO18A CTNNA1 CTNNA2 CTNNA3

4.02e-04227314GO:0051015
MousePhenoretina spots

TRPM1 CTNNA1 PDE6A

7.61e-0619293MP:0012671
DomainVINCULIN_1

CTNNA1 CTNNA2 CTNNA3

1.49e-084303PS00663
DomainAlpha_catenin

CTNNA1 CTNNA2 CTNNA3

1.49e-084303IPR001033
DomainVinculin_CS

CTNNA1 CTNNA2 CTNNA3

1.49e-084303IPR000633
DomainVinculin

CTNNA1 CTNNA2 CTNNA3

3.73e-085303PF01044
DomainVinculin/catenin

CTNNA1 CTNNA2 CTNNA3

1.30e-077303IPR006077
DomainTRPM_tetra

TRPM1 TRPM3

1.49e-054302PF16519
DomainTRPM_tetra

TRPM1 TRPM3

1.49e-054302IPR032415
DomainVitD_rcpt

NR1I2 NR1D2

2.24e-0414302IPR000324
DomainIon_trans_dom

TRPM1 TRPM3 SCN8A

7.97e-04114303IPR005821
DomainIon_trans

TRPM1 TRPM3 SCN8A

7.97e-04114303PF00520
Domainzf-C4

NR1I2 NR1D2

2.47e-0346302PF00105
DomainNUCLEAR_REC_DBD_1

NR1I2 NR1D2

2.47e-0346302PS00031
DomainZnf_hrmn_rcpt

NR1I2 NR1D2

2.47e-0346302IPR001628
DomainNuclear_hrmn_rcpt

NR1I2 NR1D2

2.47e-0346302IPR001723
DomainZnF_C4

NR1I2 NR1D2

2.47e-0346302SM00399
DomainNUCLEAR_REC_DBD_2

NR1I2 NR1D2

2.47e-0346302PS51030
Domain-

NR1I2 NR1D2

2.58e-03473021.10.565.10
DomainHOLI

NR1I2 NR1D2

2.69e-0348302SM00430
DomainNucl_hrmn_rcpt_lig-bd

NR1I2 NR1D2

2.69e-0348302IPR000536
DomainHormone_recep

NR1I2 NR1D2

2.69e-0348302PF00104
Domain-

NR1I2 NR1D2

3.77e-03573023.30.50.10
DomainZnf_NHR/GATA

NR1I2 NR1D2

3.90e-0358302IPR013088
DomainIQ

MYO18A SCN8A

5.79e-0371302PF00612
DomainIQ

MYO18A SCN8A

7.47e-0381302SM00015
DomainIQ_motif_EF-hand-BS

MYO18A SCN8A

9.15e-0390302IPR000048
DomainIQ

MYO18A SCN8A

9.75e-0393302PS50096
PathwayBIOCARTA_CELL2CELL_PATHWAY

CTNNA1 CTNNA2 CTNNA3

1.07e-0612253M12851
PathwayKEGG_ENDOMETRIAL_CANCER

CTNNA1 CTNNA2 CTNNA3

1.03e-0452253M19877
PathwayBIOCARTA_CELL2CELL_PATHWAY

CTNNA1 CTNNA2

1.08e-049252MM1366
PathwayWP_ENDOMETRIAL_CANCER

CTNNA1 CTNNA2 CTNNA3

1.82e-0463253M39623
PathwayKEGG_ADHERENS_JUNCTION

CTNNA1 CTNNA2 CTNNA3

2.82e-0473253M638
PathwayWP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY

CTNNA1 CTNNA2 CTNNA3

2.94e-0474253M39462
PathwayKEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC

CTNNA1 CTNNA2 CTNNA3

2.94e-0474253M16376
PathwayREACTOME_MYOGENESIS

CTNNA1 CTNNA2

8.14e-0424252MM15174
PathwayKEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION

CTNNA1 CTNNA2 CTNNA3

1.09e-03116253M2164
PathwayREACTOME_TRP_CHANNELS

TRPM1 TRPM3

1.11e-0328252MM14943
PathwayREACTOME_TRP_CHANNELS

TRPM1 TRPM3

1.11e-0328252M27241
PathwayREACTOME_MYOGENESIS

CTNNA1 CTNNA2

1.19e-0329252M853
PathwayKEGG_TIGHT_JUNCTION

CTNNA1 CTNNA2 CTNNA3

1.59e-03132253M11355
PathwayWP_NUCLEAR_RECEPTORS

NR1I2 NR1D2

2.04e-0338252MM15865
PathwayWP_NUCLEAR_RECEPTORS

NR1I2 NR1D2

2.04e-0338252M39657
PathwayKEGG_PATHWAYS_IN_CANCER

LAMB3 CTNNA1 CTNNA2 CTNNA3

2.39e-03325254M12868
Pubmed

Leucine zipper domain of HIV-1 gp41 interacted specifically with alpha-catenin.

CTNNA1 CTNNA2 CTNNA3

6.41e-10331311883950
Pubmed

The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin.

CTNNA1 CTNNA2 CTNNA3

6.41e-10331310420987
Pubmed

Heterocellular interaction enhances recruitment of alpha and beta-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependant differentiation of mammary epithelial cells.

CTNNA1 CTNNA2 CTNNA3

2.56e-09431318775424
Pubmed

Adhesion protein VSIG1 is required for the proper differentiation of glandular gastric epithelia.

CTNNA1 CTNNA2 CTNNA3

2.24e-08731321991385
Pubmed

Functional analysis of ectodermal β-catenin during external genitalia formation.

CTNNA1 CTNNA2 CTNNA3

3.58e-08831323480356
Pubmed

Lamellipodium extension and cadherin adhesion: two cell responses to cadherin activation relying on distinct signalling pathways.

CTNNA1 CTNNA2 CTNNA3

1.05e-071131314657280
Pubmed

Loss of BAF Complex in Developing Cortex Perturbs Radial Neuronal Migration in a WNT Signaling-Dependent Manner.

CTNNA1 CTNNA2 CTNNA3

7.23e-072031334220450
Pubmed

Transient receptor potential melastatin 1 (TRPM1) is an ion-conducting plasma membrane channel inhibited by zinc ions.

TRPM1 TRPM3

7.69e-07231221278253
Pubmed

αE-catenin is an autoinhibited molecule that coactivates vinculin.

CTNNA1 CTNNA3

7.69e-07231222586082
Pubmed

Monomeric α-catenin links cadherin to the actin cytoskeleton.

CTNNA1 CTNNA2

7.69e-07231223417122
Pubmed

Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas.

CTNNA2 CTNNA3

7.69e-07231224100690
Pubmed

Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis.

CTNNA1 CTNNA2 CTNNA3

8.44e-072131319129494
Pubmed

Modulation of apical constriction by Wnt signaling is required for lung epithelial shape transition.

CTNNA1 CTNNA2 CTNNA3

9.76e-072231327913639
Pubmed

Epidermal development requires ninein for spindle orientation and cortical microtubule organization.

CTNNA1 CTNNA2 CTNNA3

1.64e-062631330923192
Pubmed

The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

CTNNA1 CTNNA2 CTNNA3

1.64e-062631323077317
Pubmed

An autoinhibited structure of α-catenin and its implications for vinculin recruitment to adherens junctions.

CTNNA1 CTNNA2

2.31e-06331223589308
Pubmed

Structure of the dimerization and beta-catenin-binding region of alpha-catenin.

CTNNA1 CTNNA2

2.31e-06331210882138
Pubmed

Loss of αT-catenin alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy and ventricular arrhythmia following acute ischemia.

CTNNA1 CTNNA3

2.31e-06331222421363
Pubmed

α-Catenin-dependent cytoskeletal tension controls Yap activity in the heart.

CTNNA1 CTNNA3

2.31e-06331229467248
Pubmed

Alteration of E-cadherin and alpha N-catenin immunoreactivity in the mouse spinal cord following peripheral axotomy.

CTNNA1 CTNNA2

2.31e-0633129370228
Pubmed

Alpha-catenin is essential in intestinal adenoma formation.

CTNNA1 CTNNA2

2.31e-06331217989230
Pubmed

Bidirectional transcription from human LRRTM2/CTNNA1 and LRRTM1/CTNNA2 gene loci leads to expression of N-terminally truncated CTNNA1 and CTNNA2 isoforms.

CTNNA1 CTNNA2

4.61e-06431221708131
Pubmed

Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity.

CTNNA1 CTNNA3

4.61e-06431225305307
Pubmed

N-cadherin mediates cortical organization in the mouse brain.

CTNNA1 CTNNA2

4.61e-06431217222817
Pubmed

Mouse alpha N-catenin: two isoforms, specific expression in the nervous system, and chromosomal localization of the gene.

CTNNA1 CTNNA2

4.61e-0643128174789
Pubmed

Profound defects in pupillary responses to light in TRPM-channel null mice: a role for TRPM channels in non-image-forming photoreception.

TRPM1 TRPM3

4.61e-06431222211741
Pubmed

Chromatin Remodeling BAF155 Subunit Regulates the Genesis of Basal Progenitors in Developing Cortex.

CTNNA1 CTNNA2 CTNNA3

5.30e-063831330240734
Pubmed

Differential expression of alpha-E-catenin and alpha-N-catenin in the developing cerebral cortex.

CTNNA1 CTNNA2

7.68e-06531216457793
Pubmed

Crystal structure of a beta-catenin/BCL9/Tcf4 complex.

BCL9L CTNNA1

7.68e-06531217052462
Pubmed

Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule.

CTNNA1 CTNNA2

7.68e-0653122349235
Pubmed

Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly.

CTNNA1 CTNNA2

7.68e-06531216325583
Pubmed

Wnt-1-dependent regulation of local E-cadherin and alpha N-catenin expression in the embryonic mouse brain.

CTNNA1 CTNNA2

7.68e-0653127925023
Pubmed

The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species.

CTNNA1 CTNNA2

7.68e-0653122788574
Pubmed

BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.

BCL9L CTNNA1

1.15e-05631217113272
Pubmed

Deletion in Catna2, encoding alpha N-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation.

CTNNA1 CTNNA2

1.15e-05631212089526
Pubmed

Cadherin-dependent adhesion is required for muscle stem cell niche anchorage and maintenance.

CTNNA1 CTNNA3

1.15e-05631238456551
Pubmed

The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome.

CTNNA1 CTNNA2

1.15e-05631224080911
Pubmed

Requirement for N-cadherin-catenin complex in heart development.

CTNNA1 CTNNA3

1.15e-05631221680756
Pubmed

Switching of alpha-catenin from alphaE-catenin in the cortical ventricular zone to alphaN-catenin II in the intermediate zone.

CTNNA1 CTNNA2

1.15e-05631216185771
Pubmed

The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility.

CTNNA1 CTNNA2

1.15e-05631212975353
Pubmed

alphaE-catenin is not a significant regulator of beta-catenin signaling in the developing mammalian brain.

CTNNA1 CTNNA2

1.61e-05731218397997
Pubmed

The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin.

CTNNA1 CTNNA2

1.61e-05731212808048
Pubmed

Expression and cell membrane localization of catenins during mouse preimplantation development.

CTNNA1 CTNNA2

1.61e-0573128853988
Pubmed

A unique and specific interaction between alphaT-catenin and plakophilin-2 in the area composita, the mixed-type junctional structure of cardiac intercalated discs.

CTNNA1 CTNNA3

1.61e-05731217535849
Pubmed

The tumor-suppressor function of E-cadherin.

CTNNA1 CTNNA2

1.61e-0573129837810
Pubmed

The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration.

CTNNA1 CTNNA2

1.61e-05731212052883
Pubmed

TGF-beta3 is required for the adhesion and intercalation of medial edge epithelial cells during palate fusion.

CTNNA1 CTNNA2

2.15e-05831212068957
Pubmed

NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes.

NCOA6 NR1I2

2.15e-05831221292004
Pubmed

The genes coding for alpha and beta catenin (Catna1 and Catnb) and plakoglobin (Jup) map to mouse chromosomes 18, 9, and 11, respectively.

CTNNA1 CTNNA2

2.15e-0583127626889
Pubmed

Switching of α-Catenin From Epithelial to Neuronal Type During Lens Epithelial Cell Differentiation.

CTNNA1 CTNNA2

2.76e-05931228692740
Pubmed

Expression of catenins during mouse embryonic development and in adult tissues.

CTNNA1 CTNNA2

2.76e-0593128821035
Pubmed

NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.

CTNNA1 CTNNA2

2.76e-05931212695331
Pubmed

Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism.

CTNNA1 CTNNA2

3.44e-051031235105859
Pubmed

Alpha N-catenin deficiency causes defects in axon migration and nuclear organization in restricted regions of the mouse brain.

CTNNA1 CTNNA2

3.44e-051031216691566
Pubmed

Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study.

PIWIL4 NCOA6

3.44e-051031220721975
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

MYO18A TRPM1 ABCA13 CTNNA3

3.45e-0520831433230847
Pubmed

Scrib is required for epithelial cell identity and prevents epithelial to mesenchymal transition in the mouse.

CTNNA1 CTNNA2

4.21e-051131224095903
Pubmed

Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis.

CTNNA1 CTNNA2

4.21e-051131221844209
Pubmed

A role for chromosomal protein HMGN1 in corneal maturation.

CTNNA1 CTNNA2

4.21e-051131216466397
Pubmed

Synergistic action of nectins and cadherins generates the mosaic cellular pattern of the olfactory epithelium.

CTNNA1 CTNNA2

5.05e-051231226929452
Pubmed

Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons.

TRPM1 TRPM3

5.05e-051231219850157
Pubmed

Mechanochemical control of epidermal stem cell divisions by B-plexins.

CTNNA1 CTNNA2

5.96e-051331233637728
Pubmed

MicroRNA profile of the developing mouse retina.

TRPM1 TRPM3

6.95e-051431219933188
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

MYO18A LAMB3 CTNNA1 UTP18 HMMR PARP2 STT3B

9.72e-05125731736526897
Pubmed

Desmoplakin is essential in epidermal sheet formation.

CTNNA1 CTNNA2

1.04e-041731211781569
Pubmed

alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway.

CTNNA1 CTNNA2

1.30e-041931216543460
Pubmed

E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions.

CTNNA1 CTNNA2

1.60e-042131215775979
Pubmed

Mapping the expression of transient receptor potential channels across murine placental development.

TRPM1 TRPM3

2.10e-042431233884443
Pubmed

Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact.

CTNNA1 CTNNA2

2.10e-042431215923648
Pubmed

Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.

NCOA6 NR1I2 NR1D2

2.27e-0413331315604093
Pubmed

A protein interaction landscape of breast cancer.

MYO18A LAMB3 CTNNA1 CTNNA2 RUFY1

2.27e-0463431534591612
Pubmed

International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels.

TRPM1 TRPM3

2.28e-042531216382100
Pubmed

αE-Catenin Is a Positive Regulator of Pancreatic Islet Cell Lineage Differentiation.

CTNNA1 CTNNA2

2.47e-042631228793255
Pubmed

An introduction to TRP channels.

TRPM1 TRPM3

2.66e-042731216460286
Pubmed

The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.

CTNNA1 SASH1

3.29e-043031230480076
Pubmed

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus.

UTP18 PAF1 STT3B

3.84e-0415931334578187
Pubmed

Identification of human protein interaction domains using an ORFeome-based yeast two-hybrid fragment library.

CTNNA1 CTNNA3

3.99e-043331223718855
Pubmed

A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.

TRPM1 TRPM3

3.99e-043331219834762
Pubmed

The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.

NRXN3 SCN8A

3.99e-043331222357600
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

MYO18A BCL9L PIWIL4 NR1I2 NUP210L

5.03e-0475431535906200
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

MYO18A PDS5B NCOA6 CTNNA1 UTP18

5.67e-0477431515302935
Pubmed

Mouse model resources for vision research.

TRPM1 PDE6A

6.17e-044131221052544
Pubmed

Developmental waves of mechanosensitivity acquisition in sensory neuron subtypes during embryonic development.

TRPM1 TRPM3

7.11e-044431219322198
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

NCOA6 UTP18 PAF1 PARP2 STT3B UBQLN4

8.68e-04129431630804502
InteractionCDH12 interactions

CTNNA1 CTNNA2 CTNNA3

1.80e-0617293int:CDH12
InteractionCTNNBIP1 interactions

CTNNA1 CTNNA2 CTNNA3

3.18e-0543293int:CTNNBIP1
GeneFamilyTransient receptor potential cation channels

TRPM1 TRPM3

3.89e-0428192249
GeneFamilyNuclear hormone receptors

NR1I2 NR1D2

1.19e-034919271
CoexpressionGSE3982_EOSINOPHIL_VS_BCELL_DN

CTNNA1 CTNNA2 UTP18 RUFY1

7.42e-05198304M5411
CoexpressionGSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP

SUGP1 NCOA6 TRPM1 PAF1

7.57e-05199304M6839
CoexpressionYAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0

LAMB3 SASH1 NR1D2

7.65e-0572303M15699
CoexpressionGSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP

NCOA6 CTNNA1 UTP18 STT3B

7.72e-05200304M5623
CoexpressionYAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0

LAMB3 SASH1 NR1D2

9.71e-0578303MM867
ToppCellCOVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type

CTNNA2 PDE6A NRXN3 NUP210L CTNNA3

7.77e-0816330519c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

CTNNA2 NRXN3 NUP210L CTNNA3

3.83e-061593045335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM1 CTNNA2 NUP210L CTNNA3

4.65e-061673043edb0570e583bb527165bcd8a4c25a042054043b
ToppCellPBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters

GLDN CTNNA1 HMMR SCN8A

6.83e-061843042e0c9a2c40c892a2d435eafb31f1f838de9baf15
ToppCellmild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PIWIL4 GLDN HMMR ABCA13

8.08e-061923040445fdc670fa7b847dcd0a061d7736ddcf3519ba
ToppCellCOVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type

TRPM1 CTNNA2 CTNNA3

7.86e-05124303d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9
ToppCellCOVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type

CTNNA2 NRXN3 CTNNA3

8.83e-0512930357b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 PIWIL4 NRXN3

9.04e-051303036434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCellfacs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PIWIL4 TRPM3 SCN8A

1.06e-041373034dcb15de821439011df1bb0bbd7682d674bd725d
ToppCellfacs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PIWIL4 TRPM3 SCN8A

1.06e-04137303c05ceeb7b483324604cb3f647d2da2b3786071b1
ToppCellCOVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type

CTNNA2 NRXN3 CTNNA3

1.10e-0413930364c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCellCOVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations)

CTNNA2 TRPM3 CTNNA3

1.15e-041413037e6dcccb74e7ee90b69dc91b59491b84f3a713c9
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

CTNNA2 ABCA13 CTNNA3

1.27e-04146303c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCellCOVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type

CTNNA2 NRXN3 CTNNA3

1.33e-041483030dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass

GLDN HMMR CTNNA3

1.35e-04149303651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCellLPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TOM1L1

1.46e-04153303e7a074ea8232bacf924be78a244a8507c7e1ebc8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM1 GLDN NRXN3

1.70e-041613037d1bc73f4c82465b3f489d6737048b0cd54f22cf
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM1 GLDN NRXN3

1.70e-04161303410eef62c83c704cbfc5a1b643c4db11bbdcd81f
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM1 GLDN NRXN3

1.70e-0416130371022485da6754a2b57b4c3e758e3de4c95cc292
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM1 GLDN NRXN3

1.70e-0416130359ae8a7c9a04ecaa335b8064852a5a91a21780bd
ToppCelldroplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMB3 NUP210L SCN8A

1.76e-041633035efecdd8a069a822bc9d35b407092925a865e629
ToppCelldroplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMB3 NUP210L SCN8A

1.76e-041633030d94a427f86e62aba12c397c6d7b8cd297f3a0e5
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMB3 HMMR SCN8A

1.80e-04164303b92e7c91910d518627376166c6ea9ed333b3d07e
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LAMB3 HMMR SCN8A

1.80e-04164303a1e43c6b3e2553f5604100db6e92bf244b70c36d
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMB3 PIWIL4 ABCA13

1.86e-04166303575c325db88d6909cdf0d5e664bd9098b89d4401
ToppCellChildren_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABCA13 NUP210L UBQLN4

1.93e-041683038f0c4dfad9f6fed9dcc31795abfe77758ceb46a1
ToppCell3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NRXN3 SASH1 ABCA13

1.96e-041693032456b3e7776e8a2214972be1b4d66a3ca5480ae0
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PIWIL4 HMMR ABCA13

2.00e-04170303cf22a843ae2d9cd6693507fed2b7c6a45abea10e
ToppCellwk_08-11-Epithelial-Proximal_epithelial-basal_late|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 SPP2

2.00e-0417030383320d37f0fc74e492cfe3de18f5c499eaa9fd3e
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HMMR PARP2 SCN8A

2.10e-04173303506efcaa5afd6ed5e565c4c4def6a4505fea97c5
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GLDN NRXN3 CTNNA3

2.17e-04175303d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GLDN NRXN3 CTNNA3

2.17e-04175303454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.25e-041773039af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

GLDN CTNNA2 NRXN3

2.29e-04178303d9142151819afb0dc22bfb32a9c9dba5f553067d
ToppCellControl-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.29e-04178303aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCellILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

GLDN CTNNA2 NRXN3

2.29e-04178303611504b0a9e6318b18fba83787b03f9245c82252
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.32e-0417930304ce3673e46606f63d9c87bcba3a64c96817d812
ToppCellhuman_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CTNNA2 NRXN3 TRPM3

2.32e-0417930314fc8ccb6b215063d747643f47d780d2b237eb67
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.40e-04181303b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.44e-04182303cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCellpdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CTNNA2 NRXN3 TRPM3

2.44e-041823037b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCelldroplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GLDN TRPM3 CTNNA3

2.44e-04182303a512863304fad80acaab60a8c6107eb7c9cbac99
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.48e-04183303ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.52e-04184303cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.52e-0418430342ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCellPCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

CTNNA2 NRXN3 TRPM3

2.52e-0418430365cf3460125e3dbc34978957bc138a449f71f7df
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.56e-041853033bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCellLPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TOM1L1

2.56e-041853030c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCellControl-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.56e-041853030d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCellControl-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.56e-041853033937e026add96a396122139daf8011cfbc60e75c
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.56e-04185303c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCellLPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TOM1L1

2.60e-04186303e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SASH1 TRPM3 ABCA13

2.60e-04186303f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.60e-041863034e94158db52df41d71e67b02b9895a358eebee0f
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.60e-041863033aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.64e-0418730358d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCellLPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.64e-04187303ff26a533d310126521efe1d05cf8b9d32e524550
ToppCellLPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.64e-04187303201ff693e4756ee3e44762885b3a303a77eb535b
ToppCellLPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TOM1L1

2.68e-041883036164d467b612767ceba15de34176bcc8e8c36ab8
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMB3 NRXN3 TRPM3

2.68e-0418830343a0508d2524a5b310e89e9422843dcaab999bc3
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 CTNNA3

2.72e-041893037659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

GLDN NRXN3 CTNNA3

2.72e-041893037fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCellRA-10._Endothelium_II|World / Chamber and Cluster_Paper

NRXN3 SASH1 TRPM3

2.72e-0418930375c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCellRA-10._Endothelium_II|RA / Chamber and Cluster_Paper

NRXN3 SASH1 TRPM3

2.72e-04189303c81787a8c662db5d7814c583dd64562857629e81
ToppCellmild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GLDN ABCA13 SCN8A

2.72e-0418930394dd5d4d815449feff7ce157fe7f8234f7c81422
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

GLDN NRXN3 CTNNA3

2.72e-0418930306b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 CTNNA3

2.77e-04190303c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 CTNNA3

2.77e-04190303625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCellCOVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type

CTNNA2 NRXN3 ABCA13

2.77e-04190303e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCellPCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 CTNNA3

2.85e-0419230325378b5e4b0cea8415ff125783511fc25a56fc00
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GLDN NRXN3 CTNNA3

2.85e-04192303b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 CTNNA3

2.85e-04192303b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GLDN NRXN3 CTNNA3

2.85e-04192303bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCellPCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 CTNNA3

2.85e-041923031aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCellhuman_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

NRXN3 TOM1L1 SCN8A

2.90e-04193303503a979328c68b096680b71359a26f02fafdff35
ToppCellcontrol-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PIWIL4 GLDN ABCA13

2.90e-0419330333349830e9eba506470ad3661fad5e5a283d20ca
ToppCelldroplet-Kidney-KIDNEY-1m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CTNNA1 SPP2 NR1D2

2.94e-04194303837cee7e6147d92a2f4b86f1ed761a9bfe65b61d
ToppCellPCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMB3 NRXN3 CTNNA3

2.94e-04194303f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCellTracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

GLDN NRXN3 CTNNA3

3.03e-04196303b6226163d9fc93ecfff2115bb74408303a000490
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CTNNA2 NRXN3 TRPM3

3.03e-04196303eea354bdaf4c558df6a94ec4f2f817f7073821d9
ToppCellBronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LAMB3 PDE6A HMMR

3.08e-0419730349689a03ab31e53386dbe15c77c09ca3a14ebf4e
ToppCellmild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PIWIL4 HMMR ABCA13

3.08e-04197303bd9d57e0c873f6526dca322f4dad8e6bd692586c
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMB3 NRXN3 TRPM3

3.12e-04198303b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMB3 NRXN3 TOM1L1

3.12e-041983038d9858dcb21f20d0c040b22a2cae543eaebd54bc
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type

LAMB3 NRXN3 TRPM3

3.12e-0419830385f424cd9bb3117c9e322031024aabb87696ce47
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CTNNA2 NRXN3 TRPM3

3.12e-041983036e314dc820db9c53fe7fc7c96bed4d7d9a325160
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LAMB3 CTNNA1 ABCA13

3.17e-041993038bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMB3 NRXN3 TRPM3

3.17e-04199303a270630626df614f8605abddb7dee7c4d74f6149
ToppCellTracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

MYO18A GLDN NRXN3

3.17e-041993038dc65662c3ca1db2ba0091332f0658abc0afc5de
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

LAMB3 NRXN3 TRPM3

3.17e-04199303d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LAMB3 CTNNA1 ABCA13

3.17e-041993030c060ef64341659f4b1247d0264ac12e53a7e12e
ToppCellTracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

MYO18A GLDN NRXN3

3.17e-04199303a92718a3f1153b8d2196fd343ed5bc0ebc98cad7
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CTNNA2 NRXN3 TRPM3

3.17e-041993035f350d9c7da9ac111bf22623dd4fed7f7983c9fc
ToppCellMacroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

GLDN NRXN3 CTNNA3

3.22e-042003034dbac2f2587e87ca5a0622f50439bb5447e93c7f
ToppCellMacroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic

GLDN NRXN3 CTNNA3

3.22e-042003031314664c1721e9ecb1e2c3482a039044b0fe50a9
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

LAMB3 NRXN3 TRPM3

3.22e-042003032dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellNeuronal-Excitatory-eC(RORB)-eC_2-C1R-|Neuronal / cells hierarchy compared to all cells using T-Statistic

GLDN CTNNA2 SASH1

3.22e-04200303891a80cbde575f81f3466217175f41e1d4f66d5e
ToppCellMacroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic

GLDN NRXN3 CTNNA3

3.22e-042003038b229f095fc113aecfc94b64862a9e0fdcc363ce
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

LAMB3 NRXN3 TRPM3

3.22e-04200303ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellMacroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

GLDN NRXN3 CTNNA3

3.22e-04200303272909f4354f3ae22e2b2f8f35970e6b0e92cfe2
DrugSalisorosides Rosavin

NCOA6 CTNNA1 CTNNA2 PAF1 CTNNA3

3.43e-0871305CID003340349
Drugajm

CTNNA1 CTNNA2 CTNNA3

1.14e-0616303CID006323214
DrugUCS15A

CTNNA1 CTNNA2 CTNNA3

2.70e-0621303CID005311041
DrugAC1L9JC0

CTNNA1 CTNNA2 CTNNA3

3.59e-0623303CID000446228
Drugbosentan

TRPM1 NR1I2 PAF1 TRPM3

1.11e-05106304CID000104865
Drugandrostan-3-ol

NCOA6 NR1I2

2.51e-056302ctd:C000658
Drugfuniferine N-oxide

CTNNA1 CTNNA2 CTNNA3

3.65e-0549303CID000191631
DrugnNOS inhibitor I

CTNNA1 CTNNA2 CTNNA3

4.12e-0551303CID000656911
Drug2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate

NR1I2 SCN8A

4.68e-058302ctd:C489827
Drug1,1,1-trichloroethane

NCOA6 CTNNA1 CTNNA2 CTNNA3

5.06e-05156304CID000006278
Drugp-acetaminobenzaldehyde thiosemicarbazone

CTNNA1 CTNNA2 CTNNA3

6.38e-0559303CID002733749
DrugTEMPO

CTNNA1 CTNNA2 CTNNA3

7.06e-0561303CID002724126
Drugalpha-CaM

CTNNA1 CTNNA2 CTNNA3

7.41e-0562303CID000196705
DrugAC1MM84E

CTNNA1 CTNNA2 CTNNA3

8.93e-0566303CID003256856
DrugAC1MMZLG

CTNNA1 CTNNA2 CTNNA3

9.34e-0567303CID003269220
DiseaseMASA syndrome (implicated_via_orthology)

TRPM1 TRPM3

1.95e-057292DOID:0060246 (implicated_via_orthology)
Diseaseesophageal carcinoma, gastric carcinoma

TRPM1 SASH1

1.26e-0417292EFO_0000178, EFO_0002916
Diseasepyruvate measurement

MYO18A CTNNA2 SASH1 SPP2

1.32e-04268294EFO_0010117
Diseaseprogression free survival, ovarian serous carcinoma

CTNNA2 ABCA13

2.13e-0422292EFO_0004920, EFO_1001516
DiseaseGlobal developmental delay

CTNNA2 TRPM3 STT3B

3.00e-04133293C0557874
Diseasecerebrospinal fluid clusterin measurement

CTNNA2 ABCA13

5.44e-0435292EFO_0007657
Diseasetrauma exposure measurement

NRXN3 SASH1 RUFY1

6.36e-04172293EFO_0010703
Diseasemacrophage migration inhibitory factor measurement

PIWIL4 SPP2

8.21e-0443292EFO_0008221
Diseasechildhood trauma measurement, smoking behaviour measurement

NRXN3 CTNNA3

8.99e-0445292EFO_0005671, EFO_0007979
DiseaseIntellectual Disability

CTNNA2 TRPM3 STT3B SCN8A

9.14e-04447294C3714756
Diseasealcohol consumption measurement

CTNNA1 CTNNA2 NRXN3 NR1D2 STT3B SCN8A

1.13e-031242296EFO_0007878
Diseasebody weight

CTNNA2 UTP18 NR1I2 NRXN3 TOM1L1 CTNNA3

1.23e-031261296EFO_0004338
Diseaseresponse to cranial radiation therapy, short-term memory

NRXN3 SASH1

1.59e-0360292EFO_0004335, EFO_0010950
Diseasecognitive function measurement

GLDN CTNNA2 NRXN3 NUP210L NR1D2 CTNNA3

2.36e-031434296EFO_0008354
Diseaseinitial pursuit acceleration

NRXN3 SPP2

3.31e-0387292EFO_0008434

Protein segments in the cluster

PeptideGeneStartEntry
AMEMLQKVKMMVVRV

ABCA13

2926

Q86UQ4
MLMMMTYSMVPIRVM

GLDN

111

Q6ZMI3
KMNKMMMSEEQMKLP

ERVK-16

26

P61578
MVRRLKMVVKTFMDM

PDS5B

31

Q9NTI5
CNVQAMEEMMMEMKY

PARP2

246

Q9UGN5
MEEMMMEMKYNTKKA

PARP2

251

Q9UGN5
LKKQMEVMEMEVMEA

MYO18A

1336

Q92614
MMLEQTRKEIVMAMM

PDE6A

701

P16499
SMYMKIIMPMVMHTE

NRXN3

691

Q9Y4C0
EQRMMIRELMDAQMK

NR1I2

146

O75469
MRGMMAKQEGMEMKL

HMMR

181

O75330
QQMMMMLMMQQDPKS

NCOA6

1031

Q14686
AALEMMSQAMIRGMM

PAF1

236

Q8N7H5
IIVLAKNMCMIMMEM

CTNNA3

701

Q9UI47
KNMCMIMMEMTDFTR

CTNNA3

706

Q9UI47
IIVLAKQMCMIMMEM

CTNNA2

711

P26232
KQMCMIMMEMTDFTR

CTNNA2

716

P26232
AKQMCMIMMEMTDFT

CTNNA1

716

P35221
MEMERMMQAHRQMDP

BCL9L

706

Q86UU0
FGETMEMMDRMKDME

LAMB3

1116

Q13751
KMTLIPMNMMQVMSE

NUP210L

1091

Q5VU65
RMLIEMQSAMKTMMN

NR1D2

186

Q14995
EMVDMMNNRFRKDMM

UTP18

151

Q9Y5J1
MVKMNVRVMSAILME

TOM1L1

211

O75674
KCQMMEERANLMHMM

RUFY1

106

Q96T51
GMMMSIATKIAMQMT

PIWIL4

586

Q7Z3Z4
EKMTMMMKILIMFAL

SPP2

6

Q13103
MQQMYDMIMQHKRAM

SUGP1

451

Q8IWZ8
KSIVTMLMLMLLMMF

STT3B

536

Q8TCJ2
IGKMMIDMMYFVIIM

TRPM3

1026

Q9HCF6
QLMMMVKEKMITIEE

SASH1

191

O94885
IVIMMLICLNMVTMM

SCN8A

1526

Q9UQD0
VMMIGKMMIDMLYFV

TRPM1

956

Q7Z4N2
QDMMSNPDLMRHMIM

UBQLN4

206

Q9NRR5